NUTX Stock Analysis: Buy, Sell, or Hold?
NUTX - Nutex Health Inc. Common Stock
$179.15
-4.76 (-2.59%)
▼
5d:
-7.44%
30d:
+34.08%
90d:
+77.29%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 30, 2026
16d
Get Alerted When NUTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NUTX is fairly valued with market pricing in 3.4% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: NUTX is fairly valued with market pricing in 3.4% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$210.64
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$130.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NUTX is currently trading at $179.15, which is considered slightly high relative to its 30-day fair value range of $138.61 to $180.17. From a valuation perspective, the stock is trading at a premium (Forward PE: 7.8) compared to its historical average (7.0). At these levels, the market is pricing in 3.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NUTX is in a strong uptrend. Immediate support is located at $155.57, while resistance sits at $204.00.
Market Sentiment: NUTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $246.40 (+37.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUTX is in a strong uptrend. Immediate support is located at $155.57, while resistance sits at $204.00.
Market Sentiment: NUTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $246.40 (+37.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$138.61 -
$180.17
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.5% below Wall St target ($246.40)
- NEUTRAL: Market pricing in 3.4% annual earnings growth - fairly valued
- CAUTION: Recommendation downgraded due to -7.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$138.61 -
$180.17
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$155.57
Resistance Level
$204.00
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.78
Wall Street Target
$246.40
(+37.5%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
95.9%
Profit Margin
10.9%
Valuation Premium vs History
+3.4% premium
PE vs Historical
7.8 vs 7.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$185.24
(+3%)
2-Year Target
$191.54
(+7%)
3-Year Target
$198.05
(+11%)
3-Yr Target (if PE normalizes)
(PE: 8→7)
PE COMPRESSION
$178.22
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 7.0%)
$614.76
(+243%)
Base:
(SPY PE: 7.8, Growth: 7.0%)
$219.57
(+23%)
Bear:
(PE: 6.6, Growth: 7.0%)
$186.63
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 13.15 | Current EPS (TTM): $13.94
Bull Case
$333.22
(+81%)
Analyst growth 65.2%, PE expands to 14.5
Base Case
$302.93
(+65%)
Market implied 65.2%, PE stable at 13.2
Bear Case
$124.68
(-32%)
Severe decline -20.0%, PE contracts to 11.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 5:48 PM ET
Data refreshes hourly during market hours. Next update: 6:48 PM
Data refreshes hourly during market hours. Next update: 6:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUTX showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Frank E Jaumot
BUY
150 shares
2026-03-20
Warren Hosseinion
BUY
252 shares
2026-03-19
Kelvin Spears
BUY
10 shares
2026-03-17
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |
